Literature DB >> 34039361

Comparative efficacy of intraoperative extracorporeal irradiated and alcohol-inactivated autograft reimplantation for the management of osteosarcomas-a multicentre retrospective study.

Meitao Xu1, Ming Xu2, Shuai Zhang1, Hanqing Li1, A I Qiuchi1, Xiuchun Yu3, Xu Quan Wang4,5.   

Abstract

BACKGROUND: Biologic bone reconstruction in limb salvage surgery for the treatment of malignant bone tumours has always been controversial. The various inactivation methods, their convenience and stability, the curative effects elicited and associated costs all need to be considered. This study aimed to compare the clinical efficacy of intraoperative extracorporeal irradiated reimplantation with alcohol-inactivated autograft reimplantation for limb salvage surgery in patients with osteosarcoma.
METHODS: We retrospectively analysed 28 patients with osteosarcoma, 14 patients treated with intraoperative cobalt 60 irradiation and reimplantation (group A), and 14 patients treated by alcohol-inactivated autograft reimplantation (group B). The postoperative complications and clinical efficacy of each treatment method were compared by statistical analysis.
RESULTS: The local recurrence rate was 14.3% in each group. Complete bony union was achieved in 64.3% of patients in group A and 71.4% of patients in group B. The overall 5-year survival rate was 71.4% in group A and 78.6% in group B. The mean Musculoskeletal Tumor Society (MSTS) score was 25.33 ± 4.72 (range 15-30) in group A and 24.00 ± 5.85 (range 15-30) in group B, and the mean International Society of Limb Salvage (ISOLS) score was 25.79 ± 5.13 (range 20-36) in group A and 26.14 ± 5.33 (range 20-30) in group B. P < 0.05 was considered to indicate a significant difference. The results showed that the long-term clinical efficacy did not differ significantly between the two methods.
CONCLUSIONS: In limb salvage surgery for osteosarcoma, intraoperative extracorporeal irradiation and alcohol-inactivated autograft reimplantation yielded equivalent outcomes. The alcohol-inactivated method may be a much more convenient and inexpensive way to reconstruct bone defects. Additional studies as well as more case studies are needed to fully evaluate the clinical efficacy and safety of this treatment method.

Entities:  

Keywords:  Alcohol-inactivated; Bone defects; Cobalt-irritated; Osteosarcoma; Reimplantation

Year:  2021        PMID: 34039361     DOI: 10.1186/s12957-021-02271-w

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  31 in total

1.  Limb Salvage Versus Amputation in Conventional Appendicular Osteosarcoma: a Systematic Review.

Authors:  Julio J Jauregui; Vidushan Nadarajah; Joseph Munn; Robert Pivec; Bhaveen H Kapadia; Daniel M Lerman; Aditya V Maheshwari
Journal:  Indian J Surg Oncol       Date:  2018-01-20

2.  The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.

Authors:  M P Link; A M Goorin; A W Miser; A A Green; C B Pratt; J B Belasco; J Pritchard; J S Malpas; A R Baker; J A Kirkpatrick
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

3.  What's New in Musculoskeletal Tumor Surgery.

Authors:  Peter S Rose
Journal:  J Bone Joint Surg Am       Date:  2019-12-18       Impact factor: 5.284

Review 4.  Surgical options for children with osteosarcoma.

Authors:  Robert J Grimer
Journal:  Lancet Oncol       Date:  2005-02       Impact factor: 41.316

5.  Resurfaced allograft-prosthetic composite for proximal tibial reconstruction in children: intermediate-term results of an original technique.

Authors:  Laura Campanacci; Nikolin Alì; José Manuel Pinto Silva Casanova; Jennifer Kreshak; Marco Manfrini
Journal:  J Bone Joint Surg Am       Date:  2015-02-04       Impact factor: 5.284

6.  Intraoperative Extracorporeal Irradiation and Frozen Treatment on Tumor-bearing Autografts Show Equivalent Outcomes for Biologic Reconstruction.

Authors:  Po-Kuei Wu; Cheng-Fong Chen; Chao-Ming Chen; Yu-Chi Cheng; Shang-Wen Tsai; Tain-Hsiung Chen; Wei-Ming Chen
Journal:  Clin Orthop Relat Res       Date:  2018-04       Impact factor: 4.176

7.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

8.  Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.

Authors:  Ming Xu; SongFeng Xu; XiuChun Yu
Journal:  World J Surg Oncol       Date:  2014-11-11       Impact factor: 2.754

Review 9.  Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapy.

Authors:  Fien Hoefkens; Charlotte Dehandschutter; Johan Somville; Paul Meijnders; Dirk Van Gestel
Journal:  Radiat Oncol       Date:  2016-10-12       Impact factor: 3.481

Review 10.  Review of Osteosarcoma and Current Management.

Authors:  Ryan A Durfee; Maryam Mohammed; Hue H Luu
Journal:  Rheumatol Ther       Date:  2016-10-19
View more
  4 in total

1.  Intercalary allograft reconstruction following femoral tumour resection: mid- and long-term results and benefits of adding a vascularised fibula autograft.

Authors:  Vincent Crenn; Yonis Quinette; Charlie Bouthors; Gilles Missenard; Brice Viard; Philippe Anract; Stéphane Boisgard; Eric Mascard; François Gouin
Journal:  World J Surg Oncol       Date:  2022-06-13       Impact factor: 3.253

2.  Clinical Application of Artificial Intelligence: Auto-Discerning the Effectiveness of Lidocaine Concentration Levels in Osteosarcoma Femoral Tumor Segment Resection.

Authors:  Shuqin Ni; Xin Li; Xiuna Yi
Journal:  J Healthc Eng       Date:  2022-03-28       Impact factor: 2.682

3.  Is three-dimensional-printed custom-made ultra-short stem with a porous structure an acceptable reconstructive alternative in peri-knee metaphysis for the tumorous bone defect?

Authors:  Jie Wang; Jingjing An; Li Min; Chongqi Tu; Minxun Lu; Yuqi Zhang; Jingqi Lin; Yi Luo; Yong Zhou
Journal:  World J Surg Oncol       Date:  2021-08-08       Impact factor: 2.754

4.  Revision surgeries for tumor endoprostheses around the knee joint: a mid-long-term follow-up of 20 cases.

Authors:  Pengfei Zan; Hongsheng Wang; Zhengdong Cai; Jiakang Shen; Wei Sun
Journal:  World J Surg Oncol       Date:  2022-03-10       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.